224 related articles for article (PubMed ID: 16212947)
21. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor.
Park EJ; Schroen DJ; Yang M; Li H; Li L; Chen JD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3519-24. PubMed ID: 10097068
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
23. Thyroid hormone-mediated negative transcriptional regulation of Necdin expression.
Nygård M; Becker N; Demeneix B; Pettersson K; Bondesson M
J Mol Endocrinol; 2006 Jun; 36(3):517-30. PubMed ID: 16720720
[TBL] [Abstract][Full Text] [Related]
24. Expression and hormonal regulation of coactivator and corepressor genes.
Misiti S; Schomburg L; Yen PM; Chin WW
Endocrinology; 1998 May; 139(5):2493-500. PubMed ID: 9564863
[TBL] [Abstract][Full Text] [Related]
25. Recruitment of N-CoR/SMRT-TBLR1 corepressor complex by unliganded thyroid hormone receptor for gene repression during frog development.
Tomita A; Buchholz DR; Shi YB
Mol Cell Biol; 2004 Apr; 24(8):3337-46. PubMed ID: 15060155
[TBL] [Abstract][Full Text] [Related]
26. Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex.
Kelly SN; McKenna TJ; Young LS
J Endocrinol; 2005 Jul; 186(1):33-42. PubMed ID: 16002533
[TBL] [Abstract][Full Text] [Related]
27. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
28. SMRT has tissue-specific isoform profiles that include a form containing one CoRNR box.
Short S; Malartre M; Sharpe C
Biochem Biophys Res Commun; 2005 Sep; 334(3):845-52. PubMed ID: 16026760
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants required for selective interactions between the thyroid hormone receptor homodimer and the nuclear receptor corepressor N-CoR.
Kim JY; Son YL; Kim JS; Lee YC
J Mol Biol; 2010 Feb; 396(3):747-60. PubMed ID: 20006618
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
Lim HJ; Moon I; Han K
Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
[TBL] [Abstract][Full Text] [Related]
31. Pinning down HER2-ER crosstalk in SMRT regulation.
Ryo A; Wulf G; Lee TH; Lu KP
Trends Biochem Sci; 2009 Apr; 34(4):162-5. PubMed ID: 19269830
[TBL] [Abstract][Full Text] [Related]
32. [Androgen receptor and SMRT].
Liao GQ; Tang HH; Lü XS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):157-62. PubMed ID: 16145900
[TBL] [Abstract][Full Text] [Related]
33. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
34. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
35. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
36. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
[TBL] [Abstract][Full Text] [Related]
37. Corepressor subnuclear organization is regulated by estrogen receptor via a mechanism that requires the DNA-binding domain.
Voss TC; Demarco IA; Booker CF; Day RN
Mol Cell Endocrinol; 2005 Feb; 231(1-2):33-47. PubMed ID: 15713534
[TBL] [Abstract][Full Text] [Related]
38. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
Seol W; Mahon MJ; Lee YK; Moore DD
Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
[TBL] [Abstract][Full Text] [Related]
39. The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha,25(OH)2D3 targets.
Dunlop TW; Väisänen S; Frank C; Carlberg C
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):257-60. PubMed ID: 15225781
[TBL] [Abstract][Full Text] [Related]
40. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron.
Jepsen K; Solum D; Zhou T; McEvilly RJ; Kim HJ; Glass CK; Hermanson O; Rosenfeld MG
Nature; 2007 Nov; 450(7168):415-9. PubMed ID: 17928865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
